A comparison of cisplatin plus S-1 versus mitomycin C, vindesine, and cisplatin in concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer: A target trial emulation study using a clinical trial database
A comparison of cisplatin plus S-1 versus mitomycin C, vindesine, and cisplatin in concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer: A target trial emulation study using a clinical trial database. // International Journal of Lung Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S3117504X26000458?dgcid=rss_sd_all
A comparison of cisplatin plus S-1 versus mitomycin C, vindesine, and cisplatin in concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer: A target trial emulation study using a clinical trial database. International Journal of Lung Cancer. https://www.sciencedirect.com/science/article/pii/S3117504X26000458?dgcid=rss_sd_all
“A comparison of cisplatin plus S-1 versus mitomycin C, vindesine, and cisplatin in concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer: A target trial emulation study using a clinical trial database.” International Journal of Lung Cancer.
@article{article89539,
title = {A comparison of cisplatin plus S-1 versus mitomycin C, vindesine, and cisplatin in concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer: A target trial emulation study using a clinical trial database},
journal = {International Journal of Lung Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S3117504X26000458?dgcid=rss_sd_all}
}